J. R. Medina

Discovery of GSK2656157: An Optimized PERK Inhibitor Selected for Preclinical Development.

A. Hassell, R. Gampe, J. Axten, 2013, ACS medicinal chemistry letters.

Structure-based design of potent and selective 3-phosphoinositide-dependent kinase-1 (PDK1) inhibitors.

S. Rabindran, N. Campobasso, V. Sudakin, 2011, Journal of medicinal chemistry.

Discovery of a new series of Aurora inhibitors through truncation of GSK1070916.

Ramona N Plant, M. A. Hardwicke, J. Axten, 2010, Bioorganic & medicinal chemistry letters.

High-Throughput Screening and Triage Assays Identify Small Molecules Targeting c-MYC in Cancer Cells

Anthony Della Pietra, J. R. Medina, Xin Zeng, 2021, SLAS discovery : advancing life sciences R & D.